Article
Gene Expression Profiling Stratifies IDH-Wildtype Glioblastoma With Distinct Prognoses
17 Dec 2019
Abstract excerpt
Objectives: In the present study, we aimed to determine the candidate genes that may function as biomarkers to further distinguish patients with isocitrate dehydrogenase (IDH)-wildtype glioblastoma (GBM), which are heterogeneous with respect to clinical outcomes. Materials and Methods: We selected 41 candidate genes associated with overall survival (OS) using univariate Cox regression from IDH-wildtype GBM...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
